By: Christopher Parrella, Esq., CPC, CHC, CPCO
Parrella Health Law, Boston, MA.
A Health Care Provider Defense and Compliance Firm.

A $556 million settlement announced this week should put every Medicare Advantage participant on notice. Five affiliates of Kaiser Permanente agreed to resolve allegations that they submitted invalid diagnoses to inflate risk adjustment payments under Medicare Part C. The message from the Department of Justice could not be clearer. Risk adjustment cases are hot. Whistleblowers are highly motivated. DOJ likes these cases and will invest heavily to pursue them.

According to the government, the Kaiser entities pressured physicians to add diagnoses after patient visits, even when those conditions were not evaluated or addressed in the original encounter. The alleged practice involved mining medical records for potential diagnoses, then pushing physicians to add them later through addenda, sometimes months or even a year after the visit. In many instances, patients were not informed of the newly added conditions. The result, according to DOJ, was roughly half a million added diagnoses and about $1 billion in additional Medicare payments over time.

Kaiser denies wrongdoing and frames the case as a documentation interpretation dispute rather than a quality of care issue. That distinction did not deter DOJ. The government intervened and extracted a massive settlement with a $95 million relator share paid to whistleblowers. That number alone explains why these cases keep coming.

This is exactly the type of enforcement DOJ wants. The fact patterns are document-driven. The damages are large. The conduct often spans years. The evidence is sitting inside EHRs’ audit tools and internal communications. And insiders like coders, compliance staff, and clinicians are uniquely positioned to spot pressure tactics and file qui tam suits. From the DOJ’s perspective, these cases scale well and send a strong deterrent message to the entire Medicare Advantage market.

For providers and plans, the risk is not limited to blatant fraud. Retrospective addenda, diagnosis chasing, and documentation nudging can cross the line quickly. If a condition was not assessed, treated, or monitored during the visit, adding it later to increase a risk score creates exposure. Even well-intentioned programs designed to improve documentation accuracy can be portrayed as pressure campaigns when metrics, incentives, and leadership messaging are misaligned.

This settlement also underscores a critical reality. Medicare Advantage now covers more than half of Medicare beneficiaries. DOJ has said repeatedly that it expects truthful, accurate documentation in exchange for risk-adjusted payments. When addenda are used to make it appear that conditions were addressed when they were not, prosecutors will argue the claims were knowingly false. And when whistleblowers bring credible evidence, the DOJ is increasingly willing to intervene.

Here is the call to action. If you participate in Medicare Advantage, you should immediately review your risk adjustment and documentation programs. Audit the use of addenda and late entries. Confirm that diagnoses are supported by contemporaneous clinical assessment and plan of care. Eliminate productivity targets or incentives that reward diagnosis volume. Train physicians, coders, and compliance teams on what is permitted and what is not. And preserve evidence of independent clinical judgment free from pressure.

Do not assume size or sophistication provides protection. This settlement proves the opposite. Risk adjustment enforcement is accelerating, whistleblowers are being rewarded, and the DOJ is fully engaged. Providers who act now can reduce exposure. Those who wait may find themselves reading their own press release next. If you have any questions or comments about the subject of this blog or want help stress testing your Medicare Advantage risk adjustment compliance, please contact Parrella Health Law at 857.328.0382 or Chris directly at cparrella@parrellahealthlaw.com.